'Consistent compounder' Halma on the 'buy' list of leading Wall Street bank

Goldman Sachs initiated coverage of Halma PLC with a 'buy' rating and a 3,740p price target, citing the UK industrial group as a "consistent compounder" due to its 20-year track record of 12% earnings CAGR, disciplined M&A strategy, and exposure to structurally growing markets. The bank's forecasts incorporate future acquisitions, leading to adjusted earnings estimates for 2026-2028 up to 9% above consensus, and it argues the stock's current 32x forward earnings multiple undervalues its growth potential despite its premium valuation. Shares rose 2% following the announcement.

Analysis

Goldman Sachs has initiated coverage on Halma PLC (LSE:HLMA) with a 'buy' rating and a 3,740p price target, framing the company as a 'consistent compounder'. The bank's positive thesis is anchored in Halma's two-decade track record, which includes a 12% compound annual growth rate in earnings and a disciplined acquisition strategy that has added an incremental 3% to annual sales growth. Notably, Goldman's financial model incorporates future 'generic M&A' activity, a unique approach that lifts its adjusted earnings forecasts for 2026-2028 by up to 9% above consensus. The analysis argues that Halma's current 32x forward earnings multiple is overly conservative, as it implies only 8% earnings growth, well below Goldman's own forecast of an 11.1% EPS CAGR through 2030. While Halma trades at a 55% premium to the industrial sector, this is below its 20-year average premium of 65%, suggesting further upside potential. The company's resilience is supported by its decentralized structure, which mitigates supply chain risks, and its focus on high-growth end markets like healthcare and environmental monitoring, which benefit from structural tailwinds and tightening regulations. The market reacted positively to the note, with shares rising 2% to 3,298p.

Key Decisions for Investors

• Investors with a long-term growth mandate should consider Halma's demonstrated ability to compound earnings and dividends, as highlighted by Goldman's 'buy' thesis.
• The investment case hinges on the continuation of a successful M&A strategy funded by free cash flow; therefore, monitoring acquisition execution and the maintenance of returns on capital above 14% is critical.
• While the stock carries a premium valuation, investors should weigh this against Goldman's argument that it remains below historical averages and that current market expectations for growth appear conservative relative to the company's track record and future prospects.
• Consider the stock's defensive characteristics, such as its decentralized model and exposure to non-cyclical, regulated end markets, which could provide resilience in an uncertain industrial environment.